Economic considerations on transfusion medicine and patient blood management
MetadataShow full item record
In times of escalating health-care cost, it is of great importance tocarefully assess the cost-effectiveness and appropriateness of themost resource-consuming health interventions. A long-standingand common clinical practice that has been underestimated incost and overestimated in effectiveness is the transfusion of allogeneicblood products. Studies show that this intervention comeswith largely underestimated service cost and unacceptably highutilisation variability for matched patients, thus adding billions ofunnecessary dollars to the health-care expenditure each year.Moreover, a large and increasing body of literature points to adose-dependent increase of morbidity and mortality and adverselong-term outcomes associated with transfusion whereas publishedevidence for benefit is extremely limited. This means that transfusion may be a generator for increased hospital stay andpossible re-admissions, resulting in additional billions in unnecessaryexpenditure for the health system. In contrast to this, thereare evidence-based and cost-effective treatment options availableto pre-empt and reduce allogeneic transfusions. The patientspecificrather than a product-centred application of these multiplemodalities is termed patient blood management (PBM). From ahealth-economic perspective, the expeditious implementation ofPBM programmes is clearly indicated. Both patients and payerscould benefit from this concept that has recently been endorsedthrough the World Health Assembly resolution WHA63.12.
Showing items related by title, author, creator and subject.
Hofmann, Axel; Farmer, Shannon; Towler, Simon (2012)Purpose of review: Evidence-based patient blood management (PBM) is aimed at achieving better patient outcomes by relying on a patient's own blood rather than on donor blood. This review covers the rationale behind PBM, ...
Trentino, K.; Farmer, Shannon; Swain, S.; Burrows, S.; Hofmann, Axel; Ienco, R.; Pavey, W.; Daly, F.; Van Niekerk, A.; Webb, S.; Towler, Simon; Leahy, M. (2015)Background - Red blood cell (RBC) transfusion is independently associated in a dose-dependent manner with increased intensive care unit stay, total hospital length of stay, and hospital-acquired complications. Since little ...
Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system–wide patient blood management programLeahy, M.; Trentino, K.; May, C.; Swain, S.; Chuah, H.; Farmer, Shannon (2017)© 2017 AABB BACKGROUND: Little is published on patient blood management (PBM) programs in hematology. In 2008 Western Australia announced a health system–wide PBM program with PBM staff appointments commencing in November ...